Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: update
Precision oncology is now the evidence-based standard of care for the management of many advanced non-small cell lung cancers (NSCLC). Notably, new molecular profiling technologies have permitted dynamic growth in the identification of actionable driver oncogenes including RET rearrangements. RET on...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018-07-01
|
| coleção: | Oncology Reviews |
| Assuntos: | |
| Acesso em linha: | https://www.oncologyreviews.org/index.php/or/article/view/352 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|